Advancing a Pharmaceutical-Grade Cannabis Portfolio Positioned to Address Health Needs

A player in the medical cannabis space required support to uncover and catalogue scientific evidence that established the link between specific cannabis-based metabolites and their therapeutic benefit.

Operating in an emerging landscape, Shift Health conducted a deep literature review to grade the evidence supporting the use of cannabis in particular disease settings as well as the dosages and forms that offered purported benefit. The evidence was evaluated and opportunities were prioritized to guide the R&D team in future efforts.

The database of scientific evidence was used to inform the company’s immediate research, portfolio and growth strategy to compete in the Canadian medical cannabis landscape.